Literature DB >> 28177332

A comparative study on oxidative stress role in nasal breathing impairment and obstructive sleep apnoea syndrome.

D Passali1, G Corallo1, A Petti1, M Longini2, F M Passali3, G Buonocore4, L M Bellussi1.   

Abstract

Obstructive sleep apnoea syndrome (OSAS) is a sleep disorder that leads to metabolic abnormalities and increased cardiovascular risk. This study aimed to define the expression and clinical significance of biomarkers involved in oxidative stress in patients with OSAS. A prospective study was designed to compare outcomes of oxidative stress laboratory tests in three groups of subjects. The study involved the recruitment of three groups of subjects, 10 patients with obstructive sleep apnoea syndrome with AHI > 30; 10 patients suffering from snoring at night with AHI < 15; 10 patients with nasal respiratory impairment with AHI < 5. Patients were subjected to skin prick tests for common aero-allergens, nasal endoscopy, active anterior rhinomanometry, fibrolaryngoscopy and polysomnography; and extra-routine diagnostic tests and procedures; analysis of oxidative and antioxidant (plasma thiol groups) biomarkers in blood and urine samples. No statistical differences in age, sex distribution or body mass index were present between the three groups (p > 0.05). There were significant differences in AHI among the three groups of patients (p < 0.05). No statistical significance was found in the Analysis of Variance (ANOVA) test (p > 0.05) between the levels of biomarkers of oxidative stress in the three populations studied. The results of our study show that the nose can play a role in the pathogenesis of OSAS through the production of biomarkers of oxidative stress. © Copyright by Società Italiana di Otorinolaringologia e Chirurgia Cervico-Facciale, Rome, Italy.

Entities:  

Keywords:  Biomarkers of oxidative stress; OSAS; Oxidative damage; Polysomnography

Mesh:

Year:  2016        PMID: 28177332      PMCID: PMC5317128          DOI: 10.14639/0392-100X-1361

Source DB:  PubMed          Journal:  Acta Otorhinolaryngol Ital        ISSN: 0392-100X            Impact factor:   2.124


  24 in total

1.  Urinary prostaglandin F2alpha is generated from the isoprostane pathway and not the cyclooxygenase in humans.

Authors:  Huiyong Yin; Ling Gao; Hsin-Hsiung Tai; Laine J Murphey; Ned A Porter; Jason D Morrow
Journal:  J Biol Chem       Date:  2006-11-15       Impact factor: 5.157

Review 2.  Surgical therapy of obstructive sleep apnea: a review.

Authors:  Bettina Carvalho; Jennifer Hsia; Robson Capasso
Journal:  Neurotherapeutics       Date:  2012-10       Impact factor: 7.620

3.  Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea.

Authors:  Clete A Kushida; Alejandro Chediak; Richard B Berry; Lee K Brown; David Gozal; Conrad Iber; Sairam Parthasarathy; Stuart F Quan; James A Rowley
Journal:  J Clin Sleep Med       Date:  2008-04-15       Impact factor: 4.062

4.  Effect of deferoxamine and allopurinol on non-protein-bound iron concentrations in plasma and cortical brain tissue of newborn lambs following hypoxia-ischemia.

Authors:  M Shadid; G Buonocore; F Groenendaal; R Moison; M Ferrali; H M Berger; F van Bel
Journal:  Neurosci Lett       Date:  1998-05-22       Impact factor: 3.046

5.  Predictive role of nasal functionality tests in the evaluation of patients before nocturnal polysomnographic recording.

Authors:  F M Passali; L Bellussi; S Mazzone; D Passali
Journal:  Acta Otorhinolaryngol Ital       Date:  2011-04       Impact factor: 2.124

Review 6.  Obstructive sleep apnoea syndrome: a new paradigm by chronic nocturnal intermittent hypoxia and sleep disruption.

Authors:  D M Toraldo; F DE Nuccio; M DE Benedetto; E Scoditti
Journal:  Acta Otorhinolaryngol Ital       Date:  2015-04       Impact factor: 2.124

7.  Hyoid myotomy without suspension: a surgical approach to obstructive sleep apnoea syndrome.

Authors:  E Scarano; G Della Marca; E De Corso; S Dittoni; W Di Nardo; D Meucci; G Bastanza; R Gallus; A Losurdo; E Testani; G Paludetti
Journal:  Acta Otorhinolaryngol Ital       Date:  2014-10       Impact factor: 2.124

Review 8.  Oxidative stress in patients with obstructive sleep apnoea syndrome.

Authors:  D Passali; G Corallo; S Yaremchuk; M Longini; F Proietti; G C Passali; L Bellussi
Journal:  Acta Otorhinolaryngol Ital       Date:  2015-12       Impact factor: 2.124

9.  Drug-induced sleep endoscopy as a selection tool for mandibular advancement therapy by oral device in patients with mild to moderate obstructive sleep apnoea.

Authors:  E De Corso; G Bastanza; G Della Marca; C Grippaudo; G Rizzotto; M R Marchese; A Fiorita; B Sergi; D Meucci; W Di Nardo; G Paludetti; E Scarano
Journal:  Acta Otorhinolaryngol Ital       Date:  2015-12       Impact factor: 2.124

10.  The role of drug-induced sleep endoscopy in the diagnosis and management of obstructive sleep apnoea syndrome: our personal experience.

Authors:  E DE Corso; A Fiorita; G Rizzotto; G F Mennuni; D Meucci; M Giuliani; M R Marchese; L Levantesi; G Della Marca; G Paludetti; E Scarano
Journal:  Acta Otorhinolaryngol Ital       Date:  2013-12       Impact factor: 2.124

View more
  3 in total

1.  Peripheral blood oxidative stress markers for obstructive sleep apnea-a meta-analysis.

Authors:  Yuzhui Hu; Lin Mai; Jingying Luo; Wensong Shi; Hui Xiang; Sijia Song; Liuyan Hong; Wenting Long; Biwen Mo; Miao Luo
Journal:  Sleep Breath       Date:  2022-01-03       Impact factor: 2.816

2.  Olfactory evaluation in obstructive sleep apnoea patients.

Authors:  G Magliulo; M De Vincentiis; G Iannella; A Ciofalo; B Pasquariello; A Manno; D Angeletti; A Polimeni
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-08       Impact factor: 2.124

3.  A Device Improves Signs and Symptoms of TMD.

Authors:  Davide Pietropaoli; Barry C Cooper; Eleonora Ortu; Annalisa Monaco
Journal:  Pain Res Manag       Date:  2019-05-06       Impact factor: 3.037

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.